UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 470

Sortiert nach

Resistance of Candida to azoles and echinocandins worldwide

Clinical microbiology and infection, 2019-07, Vol.25 (7), p.792-798

2019

Link zum Volltext

Verfügbarkeit prüfen

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease

mBio, 2016-09, Vol.7 (5)

2016

Link zum Volltext

Verfügbarkeit prüfen

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

Antimicrobial Agents and Chemotherapy, 2002-06, Vol.46 (6), p.1773-1780

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment‐resistant tinea corporis, a potential public health issue

British journal of dermatology (1951), 2021-01, Vol.184 (1), p.164-165

2021

Link zum Volltext

Verfügbarkeit prüfen

Potential Role of Phospholipases in Virulence and Fungal Pathogenesis

Clinical Microbiology Reviews, 2000-01, Vol.13 (1), p.122-143

Ghannoum, M. A.

2000

Link zum Volltext

Verfügbarkeit prüfen

Zygomycosis : the re-emerging fungal infection

European journal of clinical microbiology & infectious diseases, 2006-04, Vol.25 (4), p.215-229

2006

Link zum Volltext

Verfügbarkeit prüfen

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2620-2629

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

BJOG : an international journal of obstetrics and gynaecology, 2022-02, Vol.129 (3), p.412-420

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model

Antimicrobial agents and chemotherapy, 2020-09, Vol.64 (10)

2020

Link zum Volltext

Verfügbarkeit prüfen

Indoor Mold, Toxigenic Fungi, and Stachybotrys chartarum: Infectious Disease Perspective

Clinical Microbiology Reviews, 2003-01, Vol.16 (1), p.144-172

2003

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Biofilms Formed by Candida albicans and Candida parapsilosis on Bioprosthetic Surfaces

Infection and Immunity, 2002-02, Vol.70 (2), p.878-888

2002

Link zum Volltext

Verfügbarkeit prüfen

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3142-3146

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vitro and In Vivo Activity of a Novel Catheter Lock Solution against Bacterial and Fungal Biofilms

Antimicrobial agents and chemotherapy, 2018-08, Vol.62 (8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.819-826

2006

Link zum Volltext

Verfügbarkeit prüfen

Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism

Journal of Clinical Microbiology, 2003-01, Vol.41 (1), p.506-508

2003

Link zum Volltext

Verfügbarkeit prüfen

Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales

Antimicrobial agents and chemotherapy, 2015-03, Vol.59 (3), p.1745-1750

2015

Link zum Volltext

Verfügbarkeit prüfen

A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns

Journal of the American Academy of Dermatology, 2000-10, Vol.43 (4), p.641-648

2000

Link zum Volltext

Verfügbarkeit prüfen

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5150-5154

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Link zum Volltext

Verfügbarkeit prüfen

Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance

Clinical Microbiology Reviews, 1999-10, Vol.12 (4), p.501-517

1999

Link zum Volltext

Verfügbarkeit prüfen

A Novel Transdermal Application for Clearing Skin Colonization by Candida auris

Antimicrobial agents and chemotherapy, 2021-04, Vol.95 (5)

2021

Link zum Volltext

Verfügbarkeit prüfen

Agar-Based Disk Diffusion Assay for Susceptibility Testing of Dermatophytes

Journal of Clinical Microbiology, 2010-10, Vol.48 (10), p.3750-3752

2010

Link zum Volltext

Verfügbarkeit prüfen

A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis

Antimicrobial agents and chemotherapy, 2019-05, Vol.63 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model

Antimicrobial agents and chemotherapy, 2015-04, Vol.59 (4), p.1992-1997

2015

Link zum Volltext

Verfügbarkeit prüfen

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

Journal of Clinical Microbiology, 2012-06, Vol.50 (6), p.2040-2046

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 470

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(418)
Mit Volltextzugriff
(405)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(314)
Life Sciences & Biomedicine
(295)
Humans
(197)
Biological And Medical Sciences
(169)
Microbiology
(149)
Medical Sciences
(113)
Infectious Diseases
(108)
Antifungal Agents - Pharmacology
(95)
Mycology
(85)
Fundamental And Applied Biological Sciences. Psychology
(72)
Antifungal Agents
(68)
Pharmacology. Drug Treatments
(68)
Candida Albicans
(66)
Microbial Sensitivity Tests
(64)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(63)
Pharmacology & Pharmacy
(62)
Animals
(55)
Candida - Drug Effects
(46)
Candida
(45)
Male
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Resistance of Candida to azoles and echinocandins worldwide

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

Treatment‐resistant tinea corporis, a potential public health issue

Potential Role of Phospholipases in Virulence and Fungal Pathogenesis

Zygomycosis : the re-emerging fungal infection

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model

Indoor Mold, Toxigenic Fungi, and Stachybotrys chartarum: Infectious Disease Perspective

Comparison of Biofilms Formed by Candida albicans and Candida parapsilosis on Bioprosthetic Surfaces

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

In Vitro and In Vivo Activity of a Novel Catheter Lock Solution against Bacterial and Fungal Biofilms

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism

Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales

A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis

Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance

A Novel Transdermal Application for Clearing Skin Colonization by Candida auris

Agar-Based Disk Diffusion Assay for Susceptibility Testing of Dermatophytes

A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis

VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

Suchergebnisse filtern